BioFuture

BioFuture is a premier conference that focuses on the evolution and transformation of the biopharma and healthcare ecosystem. It is a must-attend event for professionals who want to engage with the future of life sciences and understand its profound impact on healthcare. The conference brings together a diverse range of stakeholders, including biotech, technology, pharmaceutical companies, service providers, patients, and the financial community, all working collaboratively to foster cross-collaboration and investment aimed at accelerating the development of innovative treatments.

Key influencers from various sectors will lead discussions about the future of the industry, providing raw debates and unfiltered insights that challenge conventional thinking.

With a commitment to inspiring attendees, BioFuture promises to be an enlightening experience that promotes growth and innovation within the life sciences industry. Attendees will hear from notable speakers, including Sara Demy, CEO & Founder of Demy-Colton, and Art Pappas, Founder & Managing Partner of Pappas Capital, who underscore the necessity of honest discussions among scientists, industry leaders, patients, and policymakers.

The event will also feature insights from Dennis Purcell, Founder & Senior Advisor of Aisling Capital, and Kimberly Ha, CEO & Founder of KKH Advisors. They will address the intersection of healthcare with digital and technological advancements, covering topics such as disruptive technologies, the role of AI and machine learning in improving healthcare outcomes, and the importance of real-time data collection for empowering both patients and providers.

BioFuture is set to take place in New York at the venue Cure, emphasizing its appeal to a broad audience across the United States.